The Fund Grade · free · no account needed
What grade does WVALX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
Weitz Large Cap Equity Fund - Investor Class
#181 of 500 graded active funds · blend · large segment peer group
The point · specialist footprint
WVALX puts more of its book behind proven specialists than 73% of graded funds.
Bottom 20%
Bottom 40%
Middle
● Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8% per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.
10,000+ funds tracked · the graded specialists among them drive every read
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
WVALX vs the Honor Roll · share card ↗Conviction exposure
40.3%
of the book in specialist-converged names
Late-stage weight
21.4%
of the book in Crowded or Fading names
Active share
86.5%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
WVALX earns a B grade and sits in the top third of graded funds, with specialists holding about 40% of the book. The most striking thing is a 6% position in Thermo Fisher Scientific and a 4.8% stake in Vulcan Materials, both at Early Conviction stage, while Alphabet and AON together make up over 10% of the fund and specialists are leaving both.
→ Watch the combined 10.2% weight in fading Alphabet and AON closely, as specialist exits from both positions at once is a meaningful signal.
→ Note the early positioning in Thermo Fisher and Vulcan Materials, where specialist conviction is building and the fund appears genuinely ahead of consensus.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.